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Abstract
Background: Abnormal execution of several movements in a sequence is a frequent finding in schizophrenia.
Successful performance of such motor acts requires correct integration of cortico-subcortical processes, particularly
those related to cerebellar functions. Abnormal connectivity between cortical and cerebellar regions with resulting
cognitive dysmetria has been proposed as the core dysfunction behind many signs and symptoms of
schizophrenia. The aim of the present study was to assess if these proposed abnormalities in connectivity are a
unifying feature of schizophrenia, or, rather, reflect a specific symptom domain of a heterogeneous disease. We
predicted that abnormal functional connectivity between the motor cortex and cerebellum would be linked with
abnormal performance of movement sequencing.
Methods: We examined 24 schizophrenia patients (SCH) and 24 age-, sex-, and handedness-matched healthy
controls (HC) using fMRI during a modified finger-tapping task. The ability to perform movement sequencing was
tested using the Neurological Evaluation Scale (NES). The subjects were categorized into two groups, with (SQ+)
and without (SQ-) movement sequencing abnormalities, according to the NES-SQ score. The effects of diagnosis
and movement sequencing abnormalities on the functional connectivity parameters between the motor cortex
and cerebellum (MC-CRBL) and the supplementary motor cortex and cerebellum (SMA-CRBL) activated during the
motor task were analyzed.
Results: We found no effect of diagnosis on the functional connectivity measures. There was, however, a
significant effect on the SQ group: SQ + patients showed a lower level of MC-CRBL connectivity than SQ- patients
and healthy controls. Moreover, the level of MC-CRBL and SMA-CRBL negatively correlated with the magnitude of
NES-SQ abnormalities, but with no other NES domain.
Conclusions: Abnormal cortico-cerebellar functional connectivity during the execution of a motor task is linked
with movement sequencing abnormalities in schizophrenia, but not with the diagnosis of schizophrenia per se. It
seems that specific patterns of inter-regional connectivity are linked with corresponding signs and symptoms of
clinically heterogeneous conditions such as schizophrenia.
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Background
Schizophrenia is a heterogeneous mental illness with a
variable clinical manifestation. Individual patients pre-
sent with a variable pattern of symptoms, including
abnormalities of higher integrative functions, such as
perception, thinking, cognition, and, quite frequently,
abnormalities of motor functioning. Abnormalities of
the motor system in schizophrenia are related to the
minor neurological changes that are traditionally
referred to as neurological soft signs (NSS). They
include problems with sequencing of movements (i.e.,
performance of several movements one by one in turn),
and coordination of movements (i.e., performance of
several movements simultaneously in time). Dysfunction
of movement sequencing seems to be the prominent
motor symptom in schizophrenia [1]. NSS are indepen-
dent of the extrapyramidal adverse effects of antipsycho-
tic drugs; i.e., they are not a result of the treatment
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illness.
At the level of brain physiology, schizophrenia is
linked with abnormalities of brain connectivity. Ineffi-
cient or misleading communication between functional
brain areas has been postulated to be the core dysfunc-
tion behind the clinical manifestation of the illness. Fris-
ton and Frith stressed the importance of corticocortical
connectivity-fronto-temporal connectivity– - and coined
the term ‘dysconnection’ [4]. Later, Andreasen et al.
formed the theory of cognitive dysmetria as a basic cog-
nitive dysfunction that arises from abnormal coordina-
tion in loops formed by the cortex, thalamus, and
cerebellum, with a special focus on cerebellar functions
in the fine timing of motor and cognitive events [5].
Abnormal connectivity in cortico-cerebellar loops would
lead to disorganization of complex neurophysiological
and mental processes, as seen in schizophrenia.
Although a substantial body of evidence for abnormal
brain functional connectivity in schizophrenia exists
[6,7], no overall specific pattern of connectivity changes
in schizophrenia has emerged. The heterogeneity of the
findings reflects the clinical heterogeneity of the illness,
where various phenotypes stem from different patterns
of connectivity changes.
Although an abnormal performance of movement
sequencing has been linked previously with anatomical
changes of the brain [8-10], the traditional view of NSS
pathogenesis stresses an inefficient cooperation between
cortical and subcortical areas involved in complex motor
functions [11]. The correct performance of a sequence of
movements requires accurate timing of the execution of
individual motor plans, which indicates the involvement of
the cerebellum or cooperation between cortical and cere-
bellar areas [12]. Abnormal cortico-cerebellar connectivity
would, therefore, lead to abnormalities of movement
sequencing performance, as seen in schizophrenia. Func-
tional brain connectivity in the context of movement
sequencing abnormalities has not been analyzed before.
To test the hypothesis that abnormal functional con-
nectivity between the motor cortex and cerebellum is
linked with abnormal performance of movement
sequencing rather than with the diagnosis of schizophre-
nia, we used a nontrivial sequential motor task during
fMRI examination to activate the sensorimotor system
of the brain in order to assess its functional connectivity
and to analyze the correlates of cortico-cerebellar con-
nectivity with the magnitude of motor sequencing
abnormalities in patients with schizophrenia.
Methods
Subjects
We analyzed data from 24 schizophrenia patients and 24
age-, sex-, and handedness- (all subjects were right-
handed) matched healthy controls. The diagnosis of
schizophrenia was verified using the Mini-International
Neuropsychiatric Interview (M.I.N.I.) [13]. All subjects
were treated with atypical antipsychotics; the mean daily
dose in chlorpromazine equivalents was 442 mg (SD
286). Details of the demographic and clinical parameters
are given in Table 1. The exclusion criteria were drug
dependence (based on the M.I.N.I.; subjects with a his-
tory of drug abuse, but not dependence, were included),
neurological or somatic conditions affecting the struc-
ture or function of the brain, and contraindications for
MRI examination. Two schizophrenia patients were not
able to undergo the MRI examination and were not
included in subsequent analyses.
Healthy subjects were recruited from the community,
local staff, and medical students. They were screened for
Axis I psychiatric conditions using the M.I.N.I. Details
of the demographic parameters are given in Table 1.
The exclusion criteria were drug dependence, family his-
tory of Axis I psychiatric conditions, neurological or
somatic conditions affecting the structure or function of
the brain, and contraindications for MRI examination.
The study was approved by the local ethics committee
(Ethical committee of the University Hospital Brno
Bohunice) and all subjects signed an informed consent
form.
Behavioral examination
All subjects were examined using the Neurological Eva-
luation Scale (NES) [14] to assess the expression of
abnormal movement sequencing (NSS-SQ subscale; we
also examined other domains-abnormalities of motor
coordination NSS-MC subscale, and sensory integration
NSS-SI subscale-to compare the relative frequencies of
individual domains of neurological abnormalities in our
sample). The ability to perform several movements in
time-a sequencing of movements-was assessed using the
“fist-ring test” (rapid alternation between clenching the
fist and forming a ring using the thumb and forefinger),
“fist-edge-palm test” (tapping the desk using the fist,
edge of the hand, and palm of the hand), “rhythm tap-
ping test” (reproduction of several rhythms), and the
“Ozeretski test” (both hands are placed on the table, one
palm down, one palm up, and the subject is asked to
simultaneously alternate the position of the hands). All
the tests are performed separately using both hands.
The performance is rated on a three-point scale: “0” -
normal performance, “1” - mild impairment, “2” -
marked impairment. The final score of the “Mmove-
ment sequencing domain” is a sum of all test ratings
from both hands.
Handedness was also assessed using the NES scale-it
is a performance-based evaluation- with hand domi-
nance described as right, left, or mixed.
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antipsychotic drugs was assessed using the Barnes
Akathisia Scale (BAS), the Simpson-Angus Scale (SAS),
and the Abnormal Involuntary Movement Scale
(AIMS). These scales were used to check if the NSS
were related to the medication effects, rather than to
brain abnormalities.
fMRI examination
All subjects underwent functional MRI examination in
a Philips Achieva 1.5 T scanner (FFE EPI sequence, 33
axial slices, 80 × 80, in-plane resolution 2.85 × 2.85
mm, slice thickness 3.7 mm, TR = 3 s, TE 50 ms). The
activation paradigm consisted of a sequential finger-
tapping task (repetitive tapping of the four fingers
against a board), a finger opposition task (repetitive
tapping of all fingers together against a board; included
to evaluate if typical activation of cortico-cerebellar
motor regions exists during a simple motor task), and
a motor rest condition. The conditions were performed
in 30 s blocks, and repeated 4 times (resulting in 120
images/time-points). Before entering the scanner, sub-
jects were trained to perform the movements at
around 2 Hz. Subjects were visually monitored during
the fMRI examination, and, if necessary, instructed
through headphones.
Image processing
T h ef M R Ii m a g e sw e r ep r o c e s s e du s i n gt h eS P M 8t o o l -
box (http://www.fil.ion.ucl.ac.uk/spm). They were rea-
ligned, co-registered to a high-resolution structural
image, normalized to the standard MNI space, and
smoothed using an 8 mm FWHM Gaussian kernel. The
data entered the General Linear Model (GLM) design at
a single-subject level as follows: two regressors of inter-
est were created for the sequential movement condition
and the simple opposite movement condition. The
movement and rotations estimated during the realign-
ment step were used to create six additional regressors
of no interest. Contrast images for the condition where
sequential tapping elicited higher activation compared
to the motor rest condition entered second level analy-
sis-a full factorial design with a fixed factor group (schi-
zophrenia patients, healthy subjects). This GLM design
was used for a) analysis of group differences in brain
activation during sequential motor tasks (significance
threshold p < 0.05, FWE corrected), and b) for creating
a whole-sample activation map during sequential motor
tasks (p < 0.05, FWE corrected). This whole-sample acti-
vation map was used to select coordinates in pre-
defined seed regions for subsequent functional connec-
tivity analysis (see Figure 1).
For the connectivity analysis, we extracted data from 5
mm spheres with centers at statistical local maxima in
clusters in the left motor cortex MC (BA4, precentral
gyrus, MNI oriae 3 -19 55), the suplmnaymtrcre M B6
N oriae 3-10 58), and the right cerebellum CRBL (ante-
rior lobe, culmen, MNI coordinates 12-55 -23) from all
single-subject data. The data were filtered (high-pass fil-
ter, AR), and adjusted for the effect of interest (contrast
sequencing > rest, i.e., all other effects, including head
motion parameters and mean, were filtered from the
data). Subsequently, the first eigenvariate of the seed
region BOLD time-course (i.e., the most typical repre-
sentation of the time-course containing the largest part
of the variability of the data) was extracted. The similar-
ity of time-courses between individual seed regions was
used as a measure of functional connectivity. To accom-
plish this, we performed a correlation analysis between
the seed time-courses (MC-CRBL and SMA-CRBL) of
every subject of the study. The significance of the corre-
lations was tested using the one-sample t-test.
Table 1 Demographic and behavioral characteristics
Group No. Age
(SD)
Gender
(M/F)
Abuse
(%)
FH-
SCH
(%)
Education
P/S/U (%)
Unemployment
(%)
Marital
status Si/Ma/
Di
(%)
BAS
(%)
AIMS
(%)
SAS
(%)
NSS-
T (%)
SI
(%)
MC
(%)
SQ
(%)
HC 24 31.8
(9.2)
11/13 0* 0 1/12/11*
(4.2/50/45.8)
2* (8.3) 18/5/1 (75/
20.8/4.2)
0* 0 0** 1**
(4.2)
0* 0 1**
(4.2)
SCH 24 32.8
(9.7)
11/13 5 (21) 3
(13.6)
4/17/3
(16.7/70.8/
12.5)
16 (69.6) 16/4/3 (69.6/
17.4/13)
5
(20.8)
01 5
(62.5)
21
(87.5)
8
(33.3)
3
(12.5)
16
(66.7)
SQ+ 7 36.9
(6.6)
3/4 0 1
(16.7)
1/5/1 (14.3/
71.4/14.1)
6 (85.7) 4/1/1 (66.7/
16.7/16.7)
2
(28.6)
05
(71.4)
7
(100)
1
(14.3)
2
(28.6)
7*
(100)
SQ- 17 31.1
(10.4)
8/9 5 (29) 2
(12.5)
3/12/2
(17.7/70.6/
11.8)
10 (62.5) 12/3/2 (70.6/
17.6/11.8)
3
(17.7)
01 0
(58.8)
14
(82.4)
7
(41.2)
1
(4.2)
9
(52.9)
HC- healthy controls, SCH- schizophrenia patients, SQ + schizophrenia patients with marked movement sequencing abnormalities (SQ score > 2), SQ-
schizophrenia patients without movement sequencing abnormalities; M- male, F- female; R- right, M- mixed, L- left; FH-SCH- family history of schizophrenia; P-
primary, S- secondary, U- university education; Si-single, Ma- married, Di- divorced; BAS- Barnes Akathisia Scale; AIMS- Abnormal Involuntary Movements Scale,
SAS- Simpson-Angus Scale; NSS-T- neurological soft signs total score, SI- sensory integration, MC- motor coordination, SQ- movement sequencing. Frequencies of
subjects with at least one mild impairment in NES are given here. * p < 0.05, ** p < 0.001 - significance level for group comparisons (HC vs. SCH, SQ + vs. SQ-)
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The normality of the distribution of functional connec-
tivity measures was tested using Kolmogorov-Smirnov
test. The distribution did not differ significantly from
the normal distribution; therefore, we used parametric
tests for subsequent statistical analysis.
Group differences in demographic, behavioral, and
clinical variables were tested using two-sample t-tests or
chi-square tests. The relationships between continuous
demographic, behavioral, and clinical variables were
tested using correlation analysis.
The effect of diagnosis on the functional connectivity
measures was tested using the two-sample t-test. The
effect of SQ abnormalities on the functional connectivity
measures was tested using correlation analysis between
the SQ score and MC-CRBL and SMA-CRBL. We
divided the schizophrenia patients according to the pre-
sence of marked movement sequencing abnormalities
into two subgroups: patients with at least one marked
abnormality in any SQ subtest (patients with a SQ score
higher than 2) formed a group with sequencing abnorm-
alities (SQ+), patients with at most mild abnormality in
any SQ subtests (a SQ score less than or equal to 2)
formed a group without sequencing abnormalities (SQ-).
We specified ANCOVA designs with functional connec-
tivity measures as a dependent variable, group (SQ+,
SQ-, HC) as a categorical variable, and age as a continu-
ous variable. The age parameter was included to
account for the differences in age between the two
patient subgroups and healthy controls group, since the
age matching was performed only for the whole groups.
After an omnibus test determined the significance of the
effect of the group, we performed additional post-hoc
least-significant-difference (LSD) testing of the within-
group differences. Finally, we analyzed the confounding
effects of demographic and clinical variables on connec-
tivity parameters. If there were any significant relation-
ships between these variables, we performed an analysis
of covariance with the categorical parameter group (SQ
+ × SQ-) and the continuous parameter (the confound-
ing variable) to assess its effect on group differences in
connectivity. The level of significance was set to p <
0.05.
Results
Demographic data
There were no differences in age, gender, or marital sta-
tus between the schizophrenia patients and healthy con-
trols. Healthy controls had university education more
frequently than schizophrenia patients (Chi-square 7.2,
p < 0.05). Patients were also more frequently unem-
ployed (Chi-square 18.6, p < 0.001). There were no dif-
ferences in gender, age, education, employment, or
marital status between the SQ + and SQ- patient
groups.
Behavioral and clinical data
Schizophrenia patients had higher frequencies of psy-
choactive drug abuse (1 patient with cannabis, 1 with
alcohol, and 3 with polymorphic abuse including
methamphetamine and cannabis) than healthy controls
(Chi-square 5.4, p < 0.05). There was a trend toward a
higher frequency of family history for schizophrenia in
the schizophrenia group (Chi-square 3.5, p = 0.06). Schi-
z o p h r e n i ap a t i e n t sh a dap o s i t i v eB A Ss c a l e( C h i - s q u a r e
5.6, p < 0.05) and SAS scale (Chi-square 21.8, p < 0.001)
more often than healthy controls. Schizophrenia patients
had significantly higher scores on the SAS scale (t = 47
< 0.001). No study subject had a positive AIMS score.
No significant differences were found for the BAS score.
A significantly higher proportion of schizophrenia
patients had at least one mild impairment on the NSS
scale (Chi-square 33.6, p < 0.001), NSS-SI subscale (Chi-
square 9.6, p < 0.05), and NSS-SQ subscale (Chi-square
22.6, p < 0.001). There was a trend for a higher propor-
tion of schizophrenia patients with at least one mild
impairment of the NSS-MC subscale (Chi-quare 3.2, p =
0.07). Schizophrenia patients also had a higher total
NSS score (t = 77 p < 0.001), NSS-SI score (t = 31 <
0.05), and NSS-SQ score (t = 47 < 0.001).
SQ + patients experienced more psychotic episodes (t =
27 < 0.05) than SQ- patients. There were no differences
in diagnosis, duration of illness, antipsychotic medication,
prescription of antiparkinsonian medication, rate of psy-
choactive drug abuse, or family history of schizophrenia.
There were no differences in antipsychotic daily dose in
Figure 1 Brain activation during sequential finger-tapping task.
Positive effect of condition (sequential finger-tapping task vs. rest)
on the whole group level (p < 0.05 FWE corrected). The left side of
the brain is on the left side of the image. Note that there were no
significant differences in the brain activation between schizophrenia
patients and healthy controls, nor were there any differences
between the two schizophrenia subgroups.
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groups, nor were there any significant differences in the
magnitude of the SAS, AIMS, and BAS scores. SQ +
patients had at least one impairment on the NSS-SQ
(Chi-square 4.9, p < 0.05) subscale more frequently than
SQ-patients. There were no differences in the expression
of at least one mild impairment on the NSS total scale or
the NSS-MC and NSS-SI subscales between the two
groups. SQ + patients had a higher total NSS score (t =
28 < 0.05), and NSS-SQ subscale (t = 70 < 0.001). For fre-
quencies, means, and standard deviations of demographic
and clinical data, see Tables 1 and 2.
The NSS-SQ subscale did not correlate with the number
of psychotic episodes, age, disease duration, or daily anti-
psychotic dose in chlorpromazine equivalents. There were
also no significant correlations with BAS, AIMS, or SAS
extrapyramidal scales. On the other hand, extrapyramidal
symptoms measured using the SAS scale correlated signifi-
cantly with the NSS-MC subscale (R = 0.47, p < 0.05).
Functional connectivity
Brain activation patterns during the sequential finger-
tapping task included sensorimotor cortical areas, pre-
frontal and cingular executive areas, the parietal and
temporal supramodal cortex, thalamus, basal ganglia,
and cerebellum; for details, see Figure 1 and Table 3.
There were no significant differences in the activation
pattern between schizophrenia patients and healthy con-
trols, or between SQ + and SQ- patients.
The mean of individual subject correlations between
MC and CRBL (mean r = 0.23, SD 0.16, t = 9.9, p <
0.001) and SMA and CRBL (mean r = 0.26, SD 0.16, t =
11.0, p < 0.001) BOLD signals differed significantly from
zero in the whole sample. There was a significant nega-
tive correlation between MC-CRBL and SQ score (r =
03, p < 0.05) and between SMA-CRBL and SQ score (r
= 03, p < 0.05). No other NSS subscales correlated with
the functional connectivity measures.
There was no effect of diagnosis on the functional
connectivity measures: the whole group of schizophrenia
patients did not differ from healthy controls. In the
ANCOVA design there was a significant effect of SQ on
the MC-CRBL functional connectivity measure (F = 3.4,
p < 0.05). LSD post-hoc testing revealed significant dif-
ferences between SQ + and SQ-patients and SQ +
patients and healthy controls: SQ + patients had a lower
magnitude of MC-CRBL correlations than both groups.
No differences were present between SQ- patients and
healthy controls (Figure 2). There was no significant
effect on SMA-CRBL functional connectivity measures.
Confounding effects: we found significant negative
correlations between MC-CRBL and duration of illness
(R = 03, p < 0.05). When using this variable as a covari-
ate in a subsequent ANCOVA model with connectivity
parameters as the dependent variable, there was still a
significant effect of the SQ group on MC-CRBL (F =
7.2, p < 0.05). There was no effect of education on the
magnitude of MC-CRBL and SMA-CRBL correlations
(see the group differences in education between SCH
and NC). There were also no significant correlations
between daily antipsychotic dose (in chlorpromazine
equivalents), MC-CRBL, and SMA-CRBL.
Discussion
We found a significant effect of movement sequencing
abnormalities on the functional connectivity between
the motor cortex and cerebellum during the execution
of sequential motor tasks in schizophrenia. We found a
significant negative correlation between the magnitudes
of movement sequencing abnormalities measured using
the NES scale and the level of cortico-cerebellar connec-
tivity: the more pronounced the motor abnormality, the
less similar the BOLD signal between cortical and cere-
bellar regions. Only patients with impaired movement
sequencing abilities had lower functional connectivity
than healthy controls (in contrast to patients with unim-
paired movement sequencing). This means that abnor-
mal cooperation between the cerebellum and motor
cortex during a motor task manifests as an impaired
ability to sequence movements in time.
Table 2 Clinical characteristics
Group Dg. SCH/SAF
(%)
Duration Episodes Dose AP MARTA/SDA
(%)
BAS AIMS SAS AntiPark
(%)
NSS-T SI MC
SCH 21/3 (87.5/12.5) 9.2 (7.6) 4.2(2.0) 364.5
(203.1)
13/11 (54.2/45.8) 0.7
(1.9)
0 1.2
(1.3)
3 (12.5) 4.0 (2.4) 0.9
(1.4)
0.2 (0.5)
SQ+ 5/2 (71.4/28.6) 13.8 (7.2) 5.7(1.3)* 360.6
(195.8)
4/3(57.1/42.9) 0.6
(1.1)
0 1.7
(1.5)
1 (14.3) 5.9*
(2.2)
0.3
(0.8)
0.4 (0.8)
SQ- 16/1 (94.1/5.9) 7.8 (7.4) 3.6(1.9) 366.1
(212.0)
9/8 (52.9/47.1) 0.7
(2.2)
0 1.0
(1.1)
2 (11.8) 3.2 (2.1) 1.1
(1.5)
0.06
(0.2)
SCH- schizophrenia patients, SQ + schizophrenia patients with marked movement sequencing abnormalities (SQ score > 2), SQ- schizophrenia patients without
movement sequencing abnormalities; SCH- schizophrenia, SAF- schizoaffective disorder; AP- antipsychotic medication, MARTA- multi-acting receptor-targeted
antipsychotics, SDA- serotonin-dopamine antagonists; BAS- Barnes Akathisia Scale; AIMS- Abnormal Involuntary Movements Scale, SAS- Simpson-Angus Scale;
AntiPark- antiparkinsonian medication; NSS-T- neurological soft signs total score, SI- sensory integration, MC- motor coordination, SQ- movements sequencing. *
p < 0.05, ** p < 0.001 - significance level for group comparisons (SQ + vs. SQ-)
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eeelrfntoa dsoncin’fr various signs and symptoms of
schizophrenia. Wilson et al. found right cerebellar dys-
function in a MEG study that analyzed cortico-cerebel-
lar functional connectivity during tactile stimulation of
the fingers that resulted in synchronous activation of
the postcentral cortex and cerebellum in early onset
psychosis [15]. Impaired functional connectivity between
the cerebellum and the medial part of the superior fron-
tal gyrus was observed during attentional tasks in schi-
zophrenia [16]. Abnormal functional connectivity
between the medial prefrontal cortex and the contralat-
eral cerebellum was also found during the Hayling Sen-
tence Completion Test in a high-risk sample [17], and
in children and adolescents with schizophrenia during
verbal working-memory tasks [18]. There are reports of
abnormal functional connectivity between the cerebel-
lum and cortex even at rest: parameters of resting state
functional connectivity between the frontal cortex and
cerebellum had the biggest discriminative value from a
set of several regions for classification of schizophrenia
patients and healthy controls [19]. Structural equation
modeling allowed the analysis of the connectivity para-
meters between individual nodes of a network formed
by the prefrontal cortex, thalamus, and cerebellum dur-
ing an n-back working-memory task in schizophrenia:
patients showed decreased cortico-cerebellar and tha-
lamo-cerebellar functional connectivity, but increased
thalamo-cortical functional connectivity [20].
Impaired functional cortico-cerebellar connectivity
might result from abnormalities of some node of the
cortico-subcortico-cerebellar circuits. However, several
lines of evidence indicate that cerebellar dysfunction
might have a key role in cortico-cerebellar dysconnec-
tion’ and corresponding signs and symptoms, including
movement sequencing abnormalities. Transcranial mag-
netic stimulation (TMS) data show that cerebellar acti-
vation or inhibition has a direct impact on the
functioning of the motor cortex [21]. This finding, with
the theoretical implications of the involvement of cere-
bellum in the pathogenesis of schizophrenia, provides
further support for the validity of the regions we
selected for functional connectivity analysis. Further-
more, there is evidence that sequence processing is one
of the key functions of the cerebellum [12]. There are
many findings that show cerebellar abnormalities in
schizophrenia. Cerebellar inhibition of the motor cortex
assessed by TMS is decreased in schizophrenia [22].
Table 3 Brain activation during sequential finger-tapping task
Area Brodmann Area volume (cc)
L/R
random effects: Max Value (x, y, z)
Precentral Gyrus 3, 4, 6, 44 12.8/3.1 14.5(-0 -24, 55)/8.2 (30, -10, 62)
Postcentral Gyrus 1, 2, 3, 5, 7, 40, 43 12.3/6.9 13.6(-3 -19, 38)/9.2 (45, -28, 47)
Paracentral Lobule 31 0.4/0.0 6.4(-,-19, 46)/-999.0 (0, 0, 0)
Superior Frontal Gyrus 6 1.7/1.1 9.1(-7 -9, 65)/7.9 (15, -4, 65)
Middle Frontal Gyrus 6 4.4/2.8 10.7(-7 -7, 57)/8.1 (24, -7, 51)
Inferior Frontal Gyrus 9, 44, 45, 47 2.4/0.1 9.9 (-56, 6, 25)/5.6 (53, 6, 25)
Medial Frontal Gyrus 6, 32 6.1/2.6 9.8(-6,-4, 54)/8.0 (3, 4, 50)
Cingulate Gyrus 24, 32 1.3/0.7 7.9(-3, 4, 45/. 3,4)
Insula 13, 40 5.2/0.8 8.7 (-48, -23, 19)/7.1 (50, -23, 19)
Superior Temporal Gyrus 22, 41, 42 3.3/1.0 8.2 (-50, 2, 1)/6.9 (50, 8, 1)
Transverse Temporal Gyrus 41, 42 1.4/0.3 7.8 (-56, -18, 13)/6.9 (53, -21, 13)
Superior Parietal Lobule 5, 7 3.5/0.9 10.5 (-21, -50, 61)/7.1 (24, -50, 59)
Inferior Parietal Lobule 2, 40 9.6/5.2 11.2 (-42, -31, 47)/8.2 (48, -28, 44)
Supramarginal Gyrus 40 0.5/0.0 7.4 (-42, -37, 36)/-999.0 (0, 0, 0)
Precuneus 7 3.6/0.9 8.6 (-18, -60, 51)/6.3 (18, -59, 54)
Lingual Gyrus 18 0.1/0.3 5.8 (-12, -83, -13)/6.9 (18, -77, -10)
Fusiform Gyrus 19 0.1/0.0 5.7 (-21, -80, -13)/-999.0 (0, 0, 0)
Lentiform Nucleus * 0.1/0.0 5.2 (-30, -21, 5)/-999.0 (0, 0, 0)
Claustrum * 0.1/0.0 5.8 (-27, 14, 9)/-999.0 (0, 0, 0)
Thalamus * 1.3/0.2 7.3 (-12, -21, 5)/5.7 (6, -21, 13)
Declive * 6.1/6.6 10.0 (-27, -60, -19)/10.9 (12, -54, -12)
Culmen * 2.6/4.7 9.1 (-24, -57, -19)/10.4 (9, -54, -9)
Culmen of Vermis * 0.2/0.1 8.8 (0, -65, -8)/9.3 (3, -63, -9)
Declive of Vermis * 0.4/0.5 8.4 (0, -69, -11)/8.3 (3, -69, -13)
Cerebellar Lingual * 0.3/0.7 5.6 (-3, -45, -12)/6.9 (9, -48, -14)
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tioning [23] reflects impaired cerebellar time processing
in schizophrenia. Cerebellar morphological changes are
present in schizophrenia [24]; they are linked with NSS
[25-27], including repetitive motor acts, i.e., sequences
of movements [25,28,29]. Cerebellar abnormalities are
linked to non-motor symptoms of schizophrenia, such
as cognitive dysfunction [16,30,31]. Changes in cerebel-
lar tract integrity that correlate with cognitive dysfunc-
tion [32] have been described in schizophrenia [33-35].
We were not able to find any effect of movement
sequencing abnormalities on the pattern or magnitude
of brain activation during the modified finger-tapping
task. A previous fMRI study, using a similar behavioral
paradigm, found reduced activation of the pallidum and
putamen [36]. Our data show that impaired movement
sequencing abilities are linked with brain connectivity,
rather than with the magnitude of regional activation,
which points to the original concept of NSS as a conse-
quence of impaired cooperation between system sub-
components, and not a single localized pathology [11].
On the other hand, the lack of group differences in
brain activation patterns may also reflect an inadequate
behavioral paradigm for movement sequencing examina-
tion. Although the principle behind the modified
sequential finger-tapping task is similar to the NES scale
sequencing tasks, the tasks are not identical and may
require different effort for their execution and reflect
different brain loads. Our paradigm was, however, ade-
quate for the analysis of brain connectivity in the con-
text of movement sequences, which was the primary
focus of our study.
The impaired ability to sequence movements was the
most frequent movement abnormality in schizophrenia
patients: 67% of the patients had at least one mild
impairment of movement sequencing as compared to a
33% incidence of sensory integration problems, and 13%
of motor coordination abnormalities. The pattern and
incidence of individual NSS categories are in accordance
with previous findings [1]. The relative predominance of
movement sequencing abnormalities in schizophrenia
might reflect its link to a proposed neurobiological sub-
strate of the illness-brain ‘dysconnection’.
Patients with marked movement sequencing impair-
ment had more psychotic episodes than those without
movement sequencing disturbances. Moreover, cortico-
cerebellar functional connectivity correlated negatively
with the duration of treatment. These findings may
mean that there is a progressive worsening of cortico-
cerebellar connectivity with a corresponding impairment
of movement sequencing as a result of consecutive psy-
chotic outbreaks. Our study was, however, a cross-sec-
tional comparison. Therefore, we cannot exclude the
possibility that patients with marked impairments of
movement sequencing abnormalities had such marked
impairment present from the beginning of the illness.
Previous studies show that the expression of NSS at the
time of the first episode of schizophrenia predicts a
w o r s er e s p o n s et ot r e a t m e n ta n dw o r s eo u t c o m e s
[37-39]. Abnormalities of cerebellar morphology are also
linked with poor outcomes [40]. The fact that there was
a still a significant effect of movement sequencing
abnormalities present in the post-hoc analysis of covar-
iance suggests that movement sequencing abnormalities
and their link to cortico-cerebellar connectivity are not
only the result of illness progression.
Several factors might limit our results. The most
important are the effects of antipsychotics, extrapyrami-
dal symptoms, and abuse of psychoactive substances.
The severity of movement sequencing abnormalities
does not correlate with antipsychotic treatment para-
meters, nor with the severity of extrapyramidal symp-
toms. Similarly, the differences in cortico-cerebellar
connectivity between the two patient groups are not a
result of antipsychotic treatment or extrapyramidal
symptoms. This is supported by previous findings [2,3].
These factors are, however, linked significantly with the
other NSS cluster-movement coordination abnormal-
ities-which may reflect different neurobiology and etiol-
ogy of individual movement abnormalities in
schizophrenia. Findings have shown a relationship
between the severity of cerebellar impairment and co-
morbid alcohol abuse in schizophrenia [41]. In our
study, however, there were no differences in co-morbid
psychoactive substance abuse between the two patient
groups. Finally, we assessed only the functional
Figure 2 Cortico-cerebellar functional connectivity - group
differences. Group differences in connectivity parameters between
patients with (SQ+) and without (SQ-) marked movement
sequencing abnormalities and healthy controls (HC) assessed using
the ANCOVA design. MC-CRBL - correlation between motor cortex
and cerebellar BOLD signal.
Kasparek et al. BMC Psychiatry 2012, 12:17
http://www.biomedcentral.com/1471-244X/12/17
Page 7 of 9connectivity related to movement sequencing. But the
cerebellum is involved in several other functions, includ-
ing cognitive and affective ones [42]. Based on our
study, we cannot exclude the possibility that there is a
functional dysconnection of different parts of the cortex
and cerebellum during the cerebellar functions other
than movement sequencing in SQ- patients.
Conclusion
Abnormal cortico-cerebellar functional connectivity dur-
ing the performance of a motor task is linked with
movement sequencing abnormalities in schizophrenia,
but not with the diagnosis of schizophrenia per se. It
seems that specific patterns of interregional connectivity
are linked with corresponding signs and symptoms of
clinically heterogeneous conditions such as
schizophrenia.
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